04/12/2022
8:57 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/13/2021
8:06 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2021
2:47 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2021
2:51 PM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/06/2021
11:23 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2021
11:16 PM | CNBX Pharmaceuticals (Filer)
| Form EFFECT
| |
05/10/2021
9:40 AM | CNBX Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/28/2021
6:47 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2021
11:42 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/11/2021
11:15 PM | CNBX Pharmaceuticals (Filer)
| Form EFFECT
| |
|
02/23/2021
2:27 PM | CNBX Pharmaceuticals (Filer)
| Form S-1/A
| |
01/27/2021
9:08 AM | CNBX Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/21/2020
7:54 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2020
9:35 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2020
10:21 AM | CNBX Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/02/2020
2:34 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2020
11:24 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2020
7:03 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2020
7:01 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2020
3:03 PM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/29/2019
8:04 AM | CNBX Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/07/2019
4:13 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2019
3:10 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2019
9:00 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2019
12:01 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2019
12:45 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2019
2:29 PM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2019
11:10 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2019
11:37 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/27/2019
3:05 PM | CNBX Pharmaceuticals (Filed by)
Wize Pharma, Inc. (Subject)
| Form SC 13G
| |
02/13/2019
8:25 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2019
12:21 PM | CNBX Pharmaceuticals (Reporting)
SEEDO CORP. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2019
9:37 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/14/2019
4:00 PM | CNBX Pharmaceuticals (Filer)
| Form NT 10-Q
| |
11/29/2018
1:36 PM | CNBX Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/26/2018
7:04 AM | CNBX Pharmaceuticals (Filer)
| Form 424B5
| |
09/12/2018
8:09 AM | CNBX Pharmaceuticals (Filer)
| Form 424B2
| |
08/21/2018
12:36 PM | CNBX Pharmaceuticals (Filer)
| Form 424B2
| |
08/14/2018
11:59 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2018
7:06 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/01/2018
3:31 PM | CNBX Pharmaceuticals (Filer)
| Form 424B2
| |
05/02/2018
8:38 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2018
11:07 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/30/2018
2:04 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2018
7:02 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/19/2017
2:55 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2017
8:20 AM | CNBX Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/29/2017
2:37 PM | CNBX Pharmaceuticals (Filer)
| Form NT 10-K
| |
